-
Zibotentan (INN;
development code ZD4054) is an
experimental anti-cancer drug
candidate in
development by AstraZeneca. It is an
endothelin receptor antagonist...
-
antagonists (sitaxentan, ambrisentan, atrasentan, BQ-123, sp****ntan,
zibotentan, avosentan, edonentan, aprocitentan, clazosentan),
which affect endothelin...
-
Zetran Zevalin (Biogen Idec) Ziac
Ziagen (GlaxoSmithKline)
Ziana Ziba-Rx
zibotentan (INN)
zibrofusidic acid (INN)
ziconotide (INN)
zicronapine (INN) zidapamide...
-
pharmaceutical drugs containing the 1,3,4-oxadiazole ring
include fenadiazole,
zibotentan, and tiodazosin. 1,3,4-Oxadiazole
derivatives can be
synthesized in a...
-
Fandosentan Feloprentan Macitentan Nebentan Sitaxentan Sp****ntan
Tezosentan Zibotentan Agonists:
Galanin Galanin (1-15) Galanin-like
peptide Galmic Galnon NAX...
-
Fandosentan Feloprentan Macitentan Nebentan Sitaxentan Sp****ntan
Tezosentan Zibotentan Agonists Galanin Galanin (1-15) Galanin-like
peptide Galmic Galnon NAX...
